It can all seem a bit doom and gloom when it comes to coronavirus. Whilst we are now opening the country back up again and cases in the UK are declining, it’s hard not to worry about what the future holds. Luckily, there seems to be some positive results from vaccine trials around the world. There are currently 33 potential coronavirus vaccines in clinical trials around the world, and some of them have sparked hopes for an effective treatment. Typically, vaccines need years of testing and even more time to be produced in mass. However, experts are hopeful that they can develop a vaccine for Covid-19 within a year to 18 months.
In America, two vaccine trials carried out by the biotech company Moderna and the pharmaceutical company Pfizer, suggest that both of their vaccines are producing a good immune response in their volunteers. Here in the UK, experts at Oxford University have reported ‘the night sort of immune response’ in the trial of their potential Covid-19 vaccine. Researchers around the world are working tirelessly at unprecedented speeds to develop an effective vaccine, and more than 140 candidate vaccines are now being tracked by WHO.
The UK government has now been successful in securing early access to three different vaccines that use various approaches, in order to maximise the chance that one of them will work:
- 100 million doses of the Oxford vaccine which is made from a genetically engineered virus
- 30 million doses of the BioNtech/Pfizer vaccine, which injects part of the virus’ genetic code
- 60 million doses of Valneva vaccine, which uses an inactive version of the coronavirus
They have also made a deal with the company AstraZeneca for a potential million doses of a treatment with Covid-19 neutralising antibodies which may be effective in protecting those who can’t be vaccinated, for example people who are immunocompromised.
Whilst we’re not at the finish line yet, it’s encouraging to be able to see a glimmer of light at the end of the tunnel.
If you would like to sign up to take part in trials later this year, you can do so HERE
Fancy some more good news? Click HERE